Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: MICOT PHARMA-B(02335) the EBIT is -92.71 M (-245.7%);the EPS is -0.508 (-345.2%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.09B245.71%
----
----
EPS
-0.5085345.16%
----
----
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf